Publications
-
Xu L, Pierce JL, Sanchez A, Chen KS, Shukla AA, Fustino NJ, Stuart SH, Bagrodia A, Xiao X, Guo L, Krailo MD, Shaikh F, Billmire DF, Pashankar F, Bestrashniy J, Oosterhuis JW, Gillis AJM, Xie Y, Teot L, Mora J, Poynter JN, Rakheja D, Looijenga LHJ, Draper BW, Frazier AL and Amatruda JF.
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
NATURE COMMUNICATIONS . 14(1): 2636-2636. Number of citations: 4
-
Varo A, Castañeda-Heredia A, Chamorro S, Muñoz JP, Gorostegui M, Celma MS, Lopez S, Simao M, Pérez-Jaume S and Mora J.
Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
Frontiers in oncology . 13: 1164949-1164949. Number of citations: 4
-
Valls-Esteve A, Adell NE, Pasten A, Barber-Martínez de la Torre I, Munuera-del Cerro JL and Krauel L.
Exploring the Potential of Three-Dimensional Imaging, Printing, and Modeling in Pediatric Surgical Oncology: A New Era of Precision Surgery
CHILDREN-BASEL . 10(5): 832. Number of citations: 6
-
Mora J, Castañeda-Heredia A, Gorostegui M, Varo A, Pérez-Jaume S, Simao M, Muñoz JP, Garraus-Oneca M, Cristina Larrosa Espinosa, Salvador-Marcos N, Lavarino C, Krauel L and Mañe S.
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report
Cancers . 15(9): . Number of citations: 5
-
Valls-Esteve A, Tejo-Otero A, Lustig-Gainza P, Buj-Corral I, Fenollosa-Artés F, Rubio-Palau J, Barber-Martínez de la Torre I, Munuera-del Cerro JL, Fondevila C and Krauel L.
Patient-Specific 3D Printed Soft Models for Liver Surgical Planning and Hands-On Training
Gels . 9(4): . Number of citations: 4
-
Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM.
Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma
BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Number of citations: 4
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma
Biorxiv . : .
-
Valls-Esteve A, Lustig-Gainza P, Adell NE, Tejo-Otero A, Engli M, Julian-Alvarez E, Navarro-Sureda O, Fenollosa-Artés F, Rubio-Palau J, Krauel L and Munuera-del Cerro JL.
A state-of-the-art guide about the effects of sterilization processes on 3D-printed materials for surgical planning and medical applications: A comparative study
International Journal of Bioprinting . 9(5): 145-165. Number of citations: 4
-
Mora J, Chan GC, Morgenstern DA, Nysom K, Bear MK, Tornøe K and Kushner BH.
Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events
CANCER REPORTS . 6(1): . Number of citations: 10
-
Cuadrado-Vilanova M, Burgeño-Sandoval V, Balaguer-Lluna L, Aschero MR, Castillo H, Liu, J, Pérez-Jaume S, Pascual-Pastó G, Gene-Olaciregui N, Gomez-Gonzalez S, Correa, G, Suñol M, Schaiquevich, P, Radvanyi, F, Lavarino C, Mora J, Català-Mora J, Chantada G and Carcaboso AM.
Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients
JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 9(1): 32-43. Number of citations: 3